Literature DB >> 3179293

Preparation of liposomes entrapping a high specific activity of 111In3+-bound inulin.

H Essien1, K J Hwang.   

Abstract

Targeting liposomes to specific tissues or cells require the unequivocal determination of the uptake of liposomes at the cellular level. The present report describes the preparation of liposomes entrapping a high specific activity of 111In3+-bound inulin, and the potential applications of a multiple labeling technique for characterizing the extent of uptake of liposomes by tissues or different cells in a given tissue in vivo. The labeling method involves the application of the technique of acetylacetone-mediated, ionophoric loading of 111In3+ into liposomes entrapping an inulin derivative to which a strong chelating agent, diethylenetriamine-pentaacetic acid (DTPA), is bound. Subsequent ionophoric removal of the weakly bound 111In3+ by incubating the previously 111In3+-loaded liposomes with 10 mM nitrilotriacetic acid and 100 microM tropolone at room temperature for 20 min results in the preparation of liposomes entrapping 111In3+-DTPA-inulin. Our method of preparation yields net efficiencies of converting 63-78% of the externally added 111In3+ to liposome-entrapped 111In3+-DTPA-inulin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179293     DOI: 10.1016/0005-2736(88)90502-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP).

Authors:  Jan Marik; Michaelann S Tartis; Hua Zhang; Jennifer Y Fung; Azadeh Kheirolomoom; Julie L Sutcliffe; Katherine W Ferrara
Journal:  Nucl Med Biol       Date:  2007-02       Impact factor: 2.408

Review 2.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

3.  Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.

Authors:  A Gabizon; R Chisin; S Amselem; S Druckmann; R Cohen; D Goren; I Fromer; T Peretz; A Sulkes; Y Barenholz
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.